UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response to the Letter to the Editor: Does the Risk of Death Within 48 Hours of Hip Hemiarthroplasty Differ Between Patients Treated With Cemented and Cementless Implants? A Meta-analysis of Large, National Registries

Clinical orthopaedics and related research, 2022-12, Vol.480 (12), p.2470-2471

2022

Volltextzugriff (PDF)

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

The Lancet (British edition), 2008-07, Vol.372 (9632), p.31-39

2008

Volltextzugriff (PDF)

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

The Lancet (British edition), 2007-09, Vol.370 (9591), p.949-956

2007

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement

Thrombosis and haemostasis, 2008, Vol.100 (3), p.453-461

2008

Volltextzugriff (PDF)

The Bone Cement Hypercoagulation Syndrome: Pathophysiology, Mortality, and Prevention

Clinical and Applied Thrombosis/Hemostasis, 2023-01, Vol.29, p.10760296231198036-10760296231198036

2023

Volltextzugriff (PDF)

Low-molecular-weight heparin for hip fracture patients treated with osteosynthesis: should thromboprophylaxis start before or after surgery? An observational study of 45,913 hip fractures reported to the Norwegian Hip Fracture Register

Acta orthopaedica, 2018-11, Vol.89 (6), p.615-621

2018

Volltextzugriff (PDF)

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

Journal of clinical pharmacology, 2005-05, Vol.45 (5), p.555-565

2005

Volltextzugriff (PDF)

Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures: An observational study of 20,241 hemiprostheses reported to the Norwegian Hip Fracture Register

Acta orthopaedica, 2017-01, Vol.88 (1), p.48-54

2017

Volltextzugriff (PDF)

Sement – ikke for alle

Tidsskrift for den Norske Lægeforening, 2023-12, Vol.143

Dahl, Ola E.

2023

Volltextzugriff (PDF)

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement: The METHRO III study

Thrombosis and haemostasis, 2003-02, Vol.89 (2), p.288-296

2003

Volltextzugriff (PDF)

Does the Risk of Death Within 48 Hours of Hip Hemiarthroplasty Differ Between Patients Treated with Cemented and Cementless Implants? A Meta-analysis of Large, National Registries

Clinical orthopaedics and related research, 2022-02, Vol.480 (2), p.343-350

2022

Volltextzugriff (PDF)

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Chest, 2012-02, Vol.141 (2 Suppl), p.e278S-e325S

2012

Volltextzugriff (PDF)

Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly

International orthopaedics, 2011-06, Vol.35 (6), p.903-907

2011

Volltextzugriff (PDF)

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial

Thrombosis and haemostasis, 2011-04, Vol.105 (4), p.721-729

2011

Volltextzugriff (PDF)

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies

Thrombosis and haemostasis, 2007-06, Vol.97 (6), p.931-937

2007

Volltextzugriff (PDF)

Letter to the Editor: Cemented or Uncemented Hemiarthroplasty for Femoral Neck Fracture? Data from the Norwegian Hip Fracture Register

Clinical orthopaedics and related research, 2020-03, Vol.478 (3), p.685-686

2020

Volltextzugriff (PDF)

Fatal vascular outcomes following major orthopedic surgery

Thrombosis and haemostasis, 2005-05, Vol.93 (5), p.860-866

2005

Volltextzugriff (PDF)

Thromboembolism in major joint prosthetic surgery: False or fact

Journal of thrombosis and haemostasis, 2019-10, Vol.17 (10), p.1623-1625

2019

Volltextzugriff (PDF)

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

Circulation (New York, N.Y.), 2006-11, Vol.114 (22), p.2374-2381

2006

Volltextzugriff (PDF)

Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for intervention

Seminars in thrombosis and hemostasis, 2015-03, Vol.41 (2), p.141-145

2015

Volltextzugriff (PDF)

Perioperative mortality in hip fracture patients treated with cemented and uncemented hemiprosthesis: a register study of 11,210 patients

International orthopaedics, 2013-06, Vol.37 (6), p.1135-1140

2013

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban — an Oral, Direct Factor Xa Inhibitor — in Patients Undergoing Major Orthopaedic Surgery

Clinical pharmacokinetics, 2008-01, Vol.47 (3), p.203-216

2008

Volltextzugriff (PDF)

Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients?

European geriatric medicine, 2020-08, Vol.11 (4), p.563-569

2020

Volltextzugriff (PDF)

D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism

Blood coagulation & fibrinolysis, 2016-06, Vol.27 (4), p.396-400

2016

Volltextzugriff (PDF)

Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty: Results of Separate Pooled Analyses of Phase III Multicenter Randomized Trials

Circulation Cardiovascular quality and outcomes, 2010-11, Vol.3 (6), p.652-660

2010

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(134)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(94)
Humans
(80)
Female
(48)
Male
(44)
Aged
(40)
Biological And Medical Sciences
(36)
Middle Aged
(36)
Medical Sciences
(34)
Orthopedics
(34)
Cardiovascular System & Cardiology
(32)
Hematology
(31)
Peripheral Vascular Disease
(30)
Surgery
(29)
Adult
(25)
Aged, 80 And Over
(25)
Arthroplasty, Replacement, Hip - Adverse Effects
(19)
Orthopedic Surgery
(19)
Risk Factors
(19)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response to the Letter to the Editor: Does the Risk of Death Within 48 Hours of Hip Hemiarthroplasty Differ Between Patients Treated With Cemented and Cementless Implants? A Meta-analysis of Large, National Registries

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement

The Bone Cement Hypercoagulation Syndrome: Pathophysiology, Mortality, and Prevention

Low-molecular-weight heparin for hip fracture patients treated with osteosynthesis: should thromboprophylaxis start before or after surgery? An observational study of 45,913 hip fractures reported to the Norwegian Hip Fracture Register

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures: An observational study of 20,241 hemiprostheses reported to the Norwegian Hip Fracture Register

Sement – ikke for alle

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement: The METHRO III study

Does the Risk of Death Within 48 Hours of Hip Hemiarthroplasty Differ Between Patients Treated with Cemented and Cementless Implants? A Meta-analysis of Large, National Registries

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies

Letter to the Editor: Cemented or Uncemented Hemiarthroplasty for Femoral Neck Fracture? Data from the Norwegian Hip Fracture Register

Fatal vascular outcomes following major orthopedic surgery

Thromboembolism in major joint prosthetic surgery: False or fact

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for intervention

Perioperative mortality in hip fracture patients treated with cemented and uncemented hemiprosthesis: a register study of 11,210 patients

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban — an Oral, Direct Factor Xa Inhibitor — in Patients Undergoing Major Orthopaedic Surgery

Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients?

D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism

Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty: Results of Separate Pooled Analyses of Phase III Multicenter Randomized Trials

Suchergebnisse filtern